Bahija Jallal, CEO; Sir John Bell, Chairman; Brian Di Donato, CFO and Head of Strategy; David Berman, Head of R&D
Products
Cancer drugs/treatments using T-Cell receptor technology
Website
www.immunocore.com
Immunocore is a global commercial-stage biotechnology company,[1] based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
^"Transformational Science that Transforms Lives - Immunocore". www.immunocore.com. Retrieved 10 November 2017.
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell...
Bahija Jallal is chief executive officer and director of the board of Immunocore. She has previously been president at MedImmune and AstraZeneca. She is...
efficacy and safety. The U.S. Food and Drug Administration (FDA) granted Immunocore's application for tebentafusp priority review, breakthrough therapy, and...
companies are represented by Evotec, Vertex Pharmaceuticals, Hypha Discovery, Immunocore among others. Milton Park has 3,400,000 sq ft (320,000 m2) of business...
Board Observer for Ginkgo BioWorks and as a board member for PathAI and Immunocore. In 2020, Dipp founded Biospring Partners with Jennifer Lum to conduct...
Global Information
